VAERS reports by lot
Sanofi Pasteur DTaP/Tdap lot U7948BA: VAERS reports
20 VAERS reports list lot U7948BA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2024-01-12 and 2025-12-08. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).
Symptom categories in these reports
A report can mention several categories, so the counts add up to more than the number of reports.
| Category | Count | % |
|---|---|---|
| Injection-site / Local reaction | 25 | 36% |
| Musculoskeletal | 10 | 14% |
| General / Systemic (non-local) | 8 | 11% |
| Allergic / Anaphylactic | 6 | 9% |
| Dermatological (non-injection-site) | 6 | 9% |
| Gastrointestinal | 5 | 7% |
| Neurological | 4 | 6% |
| Cardiac / Cardiovascular | 3 | 4% |
| Autoimmune / Immune-mediated | 2 | 3% |
| Psychiatric / Neuropsychiatric | 1 | 1% |
Where reports came from
U.S. state of the reporter, where given (top 12).
| State | Reports |
|---|---|
| Ohio | 3 |
| Illinois | 3 |
| Texas | 2 |
| Tennessee | 1 |
| Oregon | 1 |
| Michigan | 1 |
| Georgia | 1 |
| Minnesota | 1 |
| Massachusetts | 1 |
| North Carolina | 1 |
| Arizona | 1 |
| New York | 1 |
Reports by month received
| Month | Reports | Bar |
|---|---|---|
| 2024-01 | 1 | |
| 2024-02 | 1 | |
| 2024-03 | 4 | |
| 2024-04 | 3 | |
| 2024-05 | 4 | |
| 2024-06 | 4 | |
| 2024-08 | 1 | |
| 2024-10 | 1 | |
| 2025-12 | 1 |
Products recorded with this lot
- Tdap — Sanofi Pasteur (20 reports)
Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.
Related
- All Sanofi Pasteur DTaP/Tdap lots with VAERS reports
- DTaP/Tdap vaccine lot number lookup
- DTaP/Tdap vaccine side effects, trials and ingredients
- Daptacel: ingredients, package insert and side effects
- Look up a lot for any vaccine
Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): U7920AA · U7927AA · U7931AB · U7999AA · U8009AB · U8015AA
Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.